| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Paulo Vieira | Q10346865 |
| Anne O'Garra | Q4768689 | ||
| P2093 | author name string | Anne E Goldfeld | |
| Pedro L Vieira | |||
| P2860 | cites work | A novel transcription factor, T-bet, directs Th1 lineage commitment | Q22253874 |
| Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
| Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity | Q24302386 | ||
| Selective expression of an interleukin-12 receptor component by human T helper 1 cells | Q24670175 | ||
| CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms | Q24673863 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes | Q24676786 | ||
| A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells | Q24678065 | ||
| HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells | Q24802813 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Innate immune recognition | Q27860721 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Tolerance, DCs and tryptophan: much ado about IDO | Q28203295 | ||
| TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties | Q29547848 | ||
| Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 | ||
| Immunology of tuberculosis | Q29614370 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity | Q71120550 | ||
| Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo | Q71929873 | ||
| Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis | Q72042604 | ||
| CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism | Q73020157 | ||
| The role of IL-10 in promoting disease progression in leishmaniasis | Q73365816 | ||
| CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
| Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells | Q73612987 | ||
| Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10 | Q77542537 | ||
| CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice | Q78701808 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism | Q33767365 | ||
| Coordinate viral induction of tumor necrosis factor alpha and interferon beta in human B cells and monocytes | Q33839633 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide | Q33926019 | ||
| Signaling and transcription in T helper development | Q33932729 | ||
| A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice | Q34001680 | ||
| Suppressor T cells: Rebirth, function and homeostasis | Q34014450 | ||
| Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia | Q34064629 | ||
| B cells regulate autoimmunity by provision of IL-10. | Q34150590 | ||
| Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy | Q34181985 | ||
| In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. | Q34184123 | ||
| IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells | Q34318928 | ||
| Regulatory T cells in the control of immune pathology. | Q34348983 | ||
| Role of IL-10 in allergen-specific immunotherapy and normal response to allergens | Q34374552 | ||
| Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection | Q34443497 | ||
| Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance | Q34448410 | ||
| Type 1 T regulatory cells. | Q34448429 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance | Q35069619 | ||
| IL-10-producing T cells suppress immune responses in anergic tuberculosis patients | Q35159232 | ||
| Foxp3 and natural regulatory T cells: key to a cell lineage? | Q35204514 | ||
| Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression | Q35474954 | ||
| Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis | Q35546559 | ||
| Role of IL-13 in regulation of anti-tumor immunity and tumor growth | Q35581077 | ||
| IDO and tolerance to tumors | Q35628246 | ||
| Development and function of T helper 1 cells | Q35769454 | ||
| Regulatory T cells and mechanisms of immune system control | Q35852343 | ||
| CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes | Q35978587 | ||
| Regulation of immunity to parasites by T cells and T cell-derived cytokines | Q36135203 | ||
| Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. | Q36362779 | ||
| Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system | Q36363532 | ||
| Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide | Q36368582 | ||
| Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi | Q36369855 | ||
| The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. | Q36370082 | ||
| Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells | Q36370232 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. | Q36371536 | ||
| Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis | Q36376571 | ||
| Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells | Q36376864 | ||
| Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease | Q36380402 | ||
| CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
| Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo | Q36400127 | ||
| Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens | Q36954734 | ||
| Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function | Q37094107 | ||
| Induction and maintenance of anergy in mature T cells | Q37512155 | ||
| Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels | Q39383452 | ||
| Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection | Q39654413 | ||
| The curse of Prometheus is laid upon the immune system | Q40308369 | ||
| Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice | Q40404888 | ||
| Lymphocyte responses and cytokines | Q40620203 | ||
| Cytokine regulation of T-cell function: potential for therapeutic intervention | Q40713016 | ||
| Differential regulation of murine T lymphocyte subsets | Q40898191 | ||
| Oral tolerance: immune mechanisms and treatment of autoimmune diseases | Q41546336 | ||
| Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy | Q41547320 | ||
| CD4+ T-cell subsets in autoimmunity | Q41716697 | ||
| Cytokines induce the development of functionally heterogeneous T helper cell subsets | Q41732572 | ||
| T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice | Q41911811 | ||
| Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering | Q42810147 | ||
| Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination | Q43958346 | ||
| IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages | Q44173170 | ||
| Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones | Q45010858 | ||
| Interleukin-10, T regulatory cells and specific allergy treatment | Q47988592 | ||
| Modifications of CD8+ T cell function during in vivo memory or tolerance induction | Q47992203 | ||
| Secondary response to Listeria infection requires IFN-gamma but is partially independent of IL-12. | Q52051516 | ||
| CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4 | Q56903729 | ||
| Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo | Q56904016 | ||
| Twenty-first century Foxp3 | Q56987489 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients | Q61885691 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1372-1378 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage | |
| P478 | volume | 114 |
| Q60129995 | A Differential Innate Immune Response in Active and Chronic Stages of Bovine Infectious Digital Dermatitis |
| Q37351163 | A novel IL-10-producing innate lymphoid cells (ILC10) in a contact hypersensitivity mouse model. |
| Q34954952 | A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects |
| Q82761069 | A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection |
| Q47959283 | Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure |
| Q34954366 | Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells |
| Q37101126 | An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birth |
| Q35936478 | An integrated view of suppressor T cell subsets in immunoregulation |
| Q46232287 | Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis |
| Q36131035 | Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation |
| Q59053458 | Antigen-specific immunotherapy |
| Q56838012 | Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS |
| Q33709283 | Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. |
| Q33873363 | Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study |
| Q33941228 | Astragalus polysaccharides attenuate postburn sepsis via inhibiting negative immunoregulation of CD4+ CD25(high) T cells |
| Q33510346 | Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts |
| Q35893711 | Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology. |
| Q40082278 | Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice |
| Q33521270 | CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis |
| Q36228080 | CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence |
| Q60912804 | CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus |
| Q34841938 | CD4 T Cells Mediate Both Positive and Negative Regulation of the Immune Response to HIV Infection: Complex Role of T Follicular Helper Cells and Regulatory T Cells in Pathogenesis |
| Q36229713 | CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis |
| Q79629254 | CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive |
| Q50784115 | CD4+ Foxp3+ regulatory T cells in autoimmune orchitis: phenotypic and functional characterization. |
| Q33796410 | CD46-induced human Treg enhance B-cell responses |
| Q39218899 | CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway |
| Q35633922 | CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo |
| Q35944770 | CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice |
| Q41828404 | Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis |
| Q61779891 | Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis |
| Q39971245 | Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation |
| Q34073570 | Chronic inflammation and asthma |
| Q36693344 | Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma |
| Q37376148 | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |
| Q35365120 | Comparison of humoral neuroinflammation and adhesion molecule expression in two models of experimental intracerebral hemorrhage |
| Q41957299 | Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation. |
| Q42268644 | Computational modeling of tuberculous meningitis reveals an important role for tumor necrosis factor-α. |
| Q41596789 | Computational modeling predicts IL-10 control of lesion sterilization by balancing early host immunity-mediated antimicrobial responses with caseation during mycobacterium tuberculosis infection |
| Q35539329 | Cowpox virus induces interleukin-10 both in vitro and in vivo |
| Q53077428 | Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. |
| Q34374026 | Current status of interleukin-10 and regulatory T-cells in cancer |
| Q42631213 | Cutting edge: Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response |
| Q33416436 | Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients |
| Q36231942 | Deletion of Smad3 improves cardiac allograft rejection in mice |
| Q34424827 | Dendritic cell and T cell responses in children with food allergy |
| Q37276138 | Dendritic cells: a critical player in cancer therapy? |
| Q39765360 | Detergent-resistant microdomains mediate activation of host cell signaling in response to attaching-effacing bacteria |
| Q28486287 | Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis |
| Q34091062 | Differential combination of cytokine and interferon- γ +874 T/A polymorphisms determines disease severity in pulmonary tuberculosis |
| Q35865094 | Donor- but not host-derived interleukin-10 contributes to the regulation of experimental graft-versus-host disease |
| Q36259486 | Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice |
| Q52568336 | Emerging Concepts of Adaptive Immunity in Leprosy. |
| Q28275236 | Emerging roles and new functions of CD46 |
| Q84556881 | Endogenously activated interleukin-4 differentiates disease progressors and non-progressors in tuberculosis susceptible families: a 2-year biomarkers follow-up study |
| Q93090571 | Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells |
| Q47912179 | Evaluation of gene expression levels for cytokines in ocular toxoplasmosis. |
| Q30253022 | Ex vivo modulation of the Foxo1 phosphorylation state does not lead to dysfunction of T regulatory cells |
| Q36715205 | Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy |
| Q35462957 | Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling |
| Q36330066 | Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia. |
| Q34427311 | Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-γ producing T cells |
| Q26865532 | From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors |
| Q36765022 | Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology |
| Q35554595 | Functional role of regulatory lymphocytes in stroke: facts and controversies |
| Q42694566 | Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis |
| Q42348800 | Gene expression studies of host response to Salmonid alphavirus subtype 3 experimental infections in Atlantic salmon |
| Q40098383 | Host immune responses to the itch mite, Sarcoptes scabiei, in humans |
| Q37719212 | Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions |
| Q36354718 | Human dendritic cell subsets for vaccination |
| Q34064182 | IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis |
| Q37529638 | IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response |
| Q79427915 | IL-10 inhibits endothelium-dependent T cell costimulation by up-regulation of ILT3/4 in human vascular endothelial cells |
| Q33920273 | IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes |
| Q36009860 | IL-2 and IL-4 Stimulate MEK1 Expression and Contribute to T Cell Resistance against Suppression by TGF-β and IL-10 in Asthma |
| Q83358243 | IL-23-mediated epidermal hyperplasia is dependent on IL-6 |
| Q42181842 | Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4. |
| Q36213975 | Immune responses to tuberculosis in developing countries: implications for new vaccines |
| Q36028197 | Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine |
| Q35501569 | Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate |
| Q37742701 | Immunoregulation in TB: observations and implications |
| Q29636247 | Immunosuppressive strategies that are mediated by tumor cells |
| Q35861249 | Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer |
| Q54463610 | Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10. |
| Q84660581 | In vitro human TGF-β treatment converts CD4+CD25− T cells into induced T regulatory like cells |
| Q54575259 | Increased blood interleukin-10 mRNA levels in diseased free-ranging harbor porpoises (Phocoena phocoena). |
| Q29614272 | Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota |
| Q26764866 | Induction of CD4(+) Regulatory and Polarized Effector/helper T Cells by Dendritic Cells |
| Q40480675 | Induction of regulatory T cells by Opisthorchis viverrini. |
| Q36228356 | Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens |
| Q90246592 | Inflammatory microenvironment remodelling by tumour cells after radiotherapy |
| Q92190843 | Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human Toxoplasmosis Infection |
| Q44473477 | Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis |
| Q83949157 | Initial capsid-specific CD4(+) T cell responses protect against Theiler's murine encephalomyelitisvirus-induced demyelinating disease |
| Q80391038 | Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis |
| Q37964608 | Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy |
| Q36311439 | Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis |
| Q85313727 | Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis |
| Q36796532 | Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity |
| Q36691088 | Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis |
| Q38217233 | Intestinal barrier: A gentlemen's agreement between microbiota and immunity |
| Q24619574 | Intraocular and serum cytokine profiles in patients with intermediate uveitis |
| Q51824660 | Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. |
| Q36035917 | Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease |
| Q80097552 | Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation |
| Q36314099 | Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development |
| Q40101283 | Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion. |
| Q42257941 | Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production |
| Q38040302 | MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY. |
| Q26828497 | Macrophages and Uveitis in Experimental Animal Models |
| Q35140130 | Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs |
| Q64123495 | Microenvironment tailors nTreg structure and function |
| Q33359759 | Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders. |
| Q36439020 | Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants |
| Q34837867 | Multi-scale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection |
| Q33816748 | Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner |
| Q61444954 | Myeloid differentiation primary response protein 88 (MyD88)-deficient dendritic cells exhibit a skewed cytokine response to BCG |
| Q42435697 | N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells |
| Q92724043 | Nanomodulation of Macrophages in Multiple Sclerosis |
| Q36570451 | Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy |
| Q36898660 | Natural killer cells regulate T-cell proliferation during human parainfluenza virus type 3 infection |
| Q36078051 | Natural regulatory T cells in infectious disease |
| Q33869793 | Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression |
| Q37299722 | Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma |
| Q42024502 | Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. |
| Q43205550 | New frontiers in immunology. Workshop on the road ahead: future directions in fundamental and clinical immunology |
| Q37452359 | Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response |
| Q90734771 | Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis |
| Q35016533 | OX40 ligand shuts down IL-10-producing regulatory T cells |
| Q36956399 | Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis |
| Q61187690 | Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease |
| Q36245800 | Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. |
| Q37492220 | Outer membrane vesicles of a human commensal mediate immune regulation and disease protection |
| Q82819211 | Parameters influencing antigen-specific immunotherapy for Type 1 diabetes |
| Q81429723 | Parameters influencing antigen-specific immunotherapy for type 1 diabetes |
| Q34688731 | Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function |
| Q38921419 | Piliation of Lactobacillus rhamnosus GG promotes adhesion, phagocytosis, and cytokine modulation in macrophages |
| Q36073821 | Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. |
| Q36000703 | Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon |
| Q38502556 | Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis |
| Q40528343 | Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis |
| Q42720025 | Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis |
| Q33775679 | Prolonged survival of allografts induced by mycobacterial Hsp70 is dependent on CD4+CD25+ regulatory T cells. |
| Q90074887 | Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice |
| Q36986264 | RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome |
| Q43678686 | Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma |
| Q35890068 | Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy |
| Q34163676 | Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium |
| Q33925866 | Reduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice |
| Q40901418 | Regulatory T Cell Induction and Retention in the Lungs Drives Suppression of Detrimental Type 2 Th Cells During Pulmonary Cryptococcal Infection |
| Q42413953 | Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II). |
| Q36975739 | Regulatory T cells and infection: a dangerous necessity |
| Q48788015 | Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. |
| Q34356195 | Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function |
| Q80785928 | Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10 |
| Q38620803 | Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential. |
| Q36455974 | Regulatory T cells in human disease and their potential for therapeutic manipulation |
| Q37236796 | Regulatory T cells: key players in tolerance and autoimmunity. |
| Q30894765 | Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells |
| Q36667250 | Renal dendritic cells stimulate IL-10 production and attenuate nephrotoxic nephritis |
| Q61807034 | Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease |
| Q37704952 | Revisiting the tolerogenicity of epidermal Langerhans cells |
| Q33817526 | Role of IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae |
| Q36978927 | Role of T cells and dendritic cells in glomerular immunopathology. |
| Q38008336 | Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells |
| Q36162862 | Role of endogenous and induced regulatory T cells during infections |
| Q38243971 | Role of host- and pathogen-associated lipids in directing the immune response in mycobacterial infections, with emphasis on Mycobacterium avium subsp. paratuberculosis |
| Q37781064 | Role of virulence factors and host cell signaling in the recognition of Helicobacter pylori and the generation of immune responses. |
| Q30439533 | Selective roles and dysregulation of interleukin-10 in allergic disease |
| Q36403300 | Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis |
| Q42371934 | Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Enriches Regulatory T Cells via STAT6-Mediated Upregulation of TGF-β |
| Q35990060 | Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis |
| Q36907769 | Specific alloantigen self-control by regulatory T cells in organ transplantation: a review |
| Q46657722 | Specificity of regulatory T cells that modulate vascular inflammation. |
| Q36229304 | Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis |
| Q39437320 | Striking the right immunological balance prevents progression of tuberculosis |
| Q36295987 | Stroke and T-cells |
| Q35972503 | Superior Cervical Ganglia Neurons Induce Foxp3+ Regulatory T Cells via Calcitonin Gene-Related Peptide |
| Q37332780 | Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury |
| Q90055083 | T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis |
| Q34327596 | T-cell subsets in the germinal center. |
| Q90021054 | T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection |
| Q38961310 | TLR3 Signaling Promotes the Induction of Unique Human BDCA-3 Dendritic Cell Populations. |
| Q37066512 | The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression |
| Q37761493 | The Family of IL-10-secreting CD4+ T cells |
| Q41444442 | The P2X7 Receptor Contributes to the Development of the Exacerbated Inflammatory Response Associated with Sepsis. |
| Q64063170 | The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells |
| Q26865518 | The Regulation of CD4(+) T Cell Responses during Protozoan Infections |
| Q64252919 | The Role of IL-10 in Malaria: A Double Edged Sword |
| Q37175810 | The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease |
| Q40302787 | The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells |
| Q37859621 | The role of IL-10 in immune regulation during M. tuberculosis infection |
| Q33719037 | The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis |
| Q36164906 | The role of mucosal T lymphocytes in regulating intestinal inflammation |
| Q35569913 | The role of regulatory T cell defects in type I diabetes and the potential of these cells for therapy |
| Q36961031 | The role of the T-cell costimulatory molecule Tim-1 in the immune response. |
| Q36535760 | The role of virus-induced regulatory T cells in immunopathology |
| Q37872288 | The suppressive tumor microenvironment: a challenge in cancer immunotherapy |
| Q36576509 | The two faces of interleukin 10 in human infectious diseases |
| Q37356076 | Therapeutic peptide vaccines for treatment of autoimmune diseases |
| Q39613283 | Therapeutic potential of semi-mature dendritic cells for tolerance induction |
| Q36309544 | Tipping the balance towards tolerance: the basis for therapeutic immune modulation by gold? |
| Q84510316 | Toll-like receptor-4 expression in infants with pertussis infection |
| Q35935751 | Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation. |
| Q37684073 | Transplanted neural stem cells modulate regulatory T, γδ T cells and corresponding cytokines after intracerebral hemorrhage in rats. |
| Q27490259 | Tregs control the development of symptomatic West Nile virus infection in humans and mice |
| Q36381918 | Tumor-infiltrating T lymphocytes: friends or foes? |
| Q37635491 | Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy |
| Q36151935 | Tuning microenvironments: induction of regulatory T cells by dendritic cells |
| Q64108546 | Turning the Tide Against Regulatory T Cells |
| Q37371463 | Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection |
| Q43033318 | Virus scores a perfect 10. |
| Q37439191 | mTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia |
| Q95643914 | miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10 |
Search more.